A growing body of epidemiological evidence has shown that alterations in the insulin-signaling pathway linked with type-2 diabetes (insulin resistance) significantly increase the risk of developing dementia and/or of progression from mild cognitive impairment (MCI) to full blown AD [2,5,6,7]. The gene discussed is INS; the disease is Cognitive impairment.